Delisting risk
NexGel (NXGL)
Manufactures customizable hydrogels and sells consumer, white-label, and licensed surgical biomaterials.
$0.3526
At close−0.01 (−1.51%)
Something off on this page? Send us feedback.
Next report
Nov 10, 2026
in 68 days
EPS estimate
−$0.24
Revenue estimate
$4.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$0.09−$0.09−$0.08−$0.11−$0.11−$0.40−$0.40Pending
Estimate−$0.10−$0.01−$0.09−$0.09−$0.07−$0.12−$0.12−$0.24
Surprise+10.0%−800.0%+11.1%−22.2%−57.1%−233.3%−233.3%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported$2.8M$2.9M$2.9M$2.8M$2.7M$3.7M$4.3MPending
Estimate$3.1M$3.5M$3.2M$3.2M$3.9M$4.3M$4.3M$4.2M
Surprise−8.9%−16.4%−9.4%−13.5%−32.2%−14.6%0.0%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.24 | — | — |
| Aug 2026 | −$0.12 | −$0.40 | −233.3% |
| Aug 2026 | −$0.12 | −$0.40 | −233.3% |
| May 2026 | −$0.07 | −$0.11 | −57.1% |
| Mar 2026 | −$0.09 | −$0.11 | −22.2% |
The latest year is open to everyone — the 32 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Jan 2020 | |||
| Sep 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | −$0.24 | — | — | $4.2M | — | — | — |
| Aug 17, 2026 | −$0.12 | −$0.40 | −233.3% | $4.3M | $4.3M | 0.0% | −33.5% |
| Aug 14, 2026 | −$0.12 | −$0.40 | −233.3% | $4.3M | $3.7M | −14.6% | +15.6% |
| May 13, 2026 | −$0.07 | −$0.11 | −57.1% | $3.9M | $2.7M | −32.2% | +1.7% |
| Mar 31, 2026 | −$0.09 | −$0.11 | −22.2% | $3.2M | $2.8M | −13.5% | −1.3% |
The latest year is open to everyone — the 32 quarters behind it read with an account. Sign in | |||||||
| Nov 11, 2025 | |||||||
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 19, 2024 | |||||||
| May 13, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Jan 28, 2020 | |||||||
| Sep 9, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||